Berberis vulgaris

From WikiMD's WELLNESSPEDIA

Berberis vulgaris, also known as barberry, is a species of shrub in the family Berberidaceae. It is native to central and southern Europe, northwest Africa, and western Asia. It is also naturalized in northern Europe, including the British Isles and Scandinavia, and North America.

Description[edit]

Berberis vulgaris is a deciduous shrub growing up to 4 meters high. The leaves are small oval, 2–5 cm long and 1–2 cm broad, with a serrated margin; they are borne in clusters of 2-5 together, subtended by a three-branched spine 3–8 mm long. The flowers are yellow, 4–6 mm across, produced on a simple raceme 20–50 mm long in late spring. The fruit is an oblong red berry 7–10 mm long and 3–5 mm broad, ripening in late summer or autumn; they are edible but very sour.

Cultivation and uses[edit]

Berberis vulgaris is cultivated for its fruits in many countries. The berries are edible and rich in vitamin C, though with a very sharp flavor. In Europe, the berries have been traditionally used as an ingredient in making jam. The plant is also grown as an ornamental plant in gardens for its attractive flowers and bright red berries.

The plant has a long history of medicinal use, dating back to ancient times. It has been used as a treatment for a variety of ailments, including digestive disorders, skin diseases, and infections. The plant contains several biologically active compounds, including berberine, which has been shown to have antimicrobial, anti-inflammatory, and antioxidant effects.

Ecology[edit]

Berberis vulgaris is a host plant for the larva of the moth species Argyresthia goedartella and Argyresthia conjugella. It is also a host plant for the rust fungus Puccinia graminis, a fungus that is very destructive to wheat crops. Because of this, cultivation of Berberis vulgaris is prohibited in many areas in the United States.

See also[edit]


This flora-related article is a stub. You can help WikiMD by expanding it.

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.